Protocol No.: PRE0404

Title
A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma
Principal Investigator
Craig, Michael
Phase
I/II
Age Group
Adult
Applicable Disease Site
Lymphoma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Sylvia McEwuen, RN, CCRC
Study Coordinator/Research Nurse
Phone: +1 304-293-1683

View on ClinicalTrials.gov